Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-022903)

Filing Details

Accession Number:: 0001209191-14-022903
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-25 12:07:40
Reporting Period:: 2014-03-25

Filing Date:: 2014-03-25
Accepted Time:: 2014-03-25 12:07:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1000694	Novavax Inc	NVAX	Biological Products, (No Disgnostic Substances) (2836)	222816046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1265801	A Barclay Phillips	C/O Novavax, Inc. 20 Firstfield Road Gaithersburg MD 20878	Svp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-25	5,000	$4.25	14,868	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.27, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.